Abstract:N-linked glycosylation is a pivotal post-translational modification that significantly influences various aspects of protein biology. Autophagy, a critical cellular process, is instrumental in cell survival and maintenance. The hepatitis B virus (HBV) has evolved mechanisms to manipulate this process to ensure its survival within host cells. Significantly, post-translational N-linked glycosylation in the large surface protein of HBV (LHBs) influences virion assembly, infectivity, and immune evasion. This study investigated the role of N-linked glycosylation of LHBs in autophagy, and its subsequent effects on HBV replication and secretion. LHBs plasmids were constructed by incorporating single-, double-, and triple-mutated N-linked glycosylation sites through amino acid substitutions at N4, N112, and N309. In comparison to the wild-type LHBs, N-glycan mutants, including N309Q, N4-309Q, N112-309Q, and N4-112-309Q, induced autophagy gene expression and led to autophagosome accumulation in hepatoma cells. Acridine orange staining of cells expressing LHBs mutations revealed impaired lysosomal acidification, suggesting potential blockage of autophagic flux at later stages. Furthermore, N-glycan mutants increased the mRNA expression of HBV surface antigen (HBsAg). Notably, N309Q significantly elevated HBx oncogene level. The LHBs mutants, particularly N309Q and N112-309Q, significantly enhanced HBV replication, whereas N309Q, N4-309Q, and N4-112-309Q markedly increased HBV progeny secretion. Remarkably, our findings demonstrated that autophagy is indispensable for the impact of N-linked glycosylation mutations in LHBs on HBV secretion, as evidenced by experiments with a 3-methyladenine (3-MA) inhibitor. Our study provides pioneering insights into the interplay between N-linked glycosylation mutations in LHBs, host autophagy, and the HBV life cycle. Additionally, we offer a new clue for further investigation into carcinogenesis of hepatocellular carcinoma (HCC). These findings underscore the potential of targeting either N-linked glycosylation modifications or the autophagic pathway for the development of innovative therapies against HBV and/or HCC.

O-glycosylation inhibition induce HBV release

Increasing LAG-3 Expression Suppresses T-cell Function in Chronic Hepatitis B

O-GlcNAcylation of SAMHD1 Indicating a Link between Metabolic Reprogramming and Anti-HBV Immunity

Inhibitory Effect of O-glycosylation Inhibition on Human Intestinal Epithelial Cells Mucin 2 Expression and Bacteria Adherence

Discovery of 5-Alkyl-2-pyrazol-oxazolidin-4-one Derivatives As Novel Hepatitis B Virus Capsid Assembly Modulators

Hepatitis B Virus X Protein Promotes Tumor Glycolysis by Downregulating Lncrna OIP5-AS1/HKDC1 in HCC

Glt25D2, an O-glycosyltransferase is related with the secretion of hepatitis B virus surface large protein

INHIBITION OF HEPATITIS B VIRUS BY COMBINED Sirnas IN VITRO

The inhibition effect of GLS4JHS on the transcription activity of covalently closed circular DNA in HepAD38 cells

Effective Inhibition of Expression of Hepatitis B Virus Genes by DNAzymes.

The N-linked glycosylation modifications in the hepatitis B surface protein impact cellular autophagy, HBV replication, and HBV secretion

DNAzymes in vitro inhibit the expression of hepatitis B virus genes

Glycometabolism regulates hepatitis C virus release

Protein O Glycosylation Regulates Activation of Hepatic Stellate Cells

Effect of Phospholipase Inhibitor Okadaic Acid on HBV Replication in HepG2.2.15 Cells

Hepatocyte-targeting and Microenvironmentally Responsive Glycolipid-Like Polymer Micelles for Gene Therapy of Hepatitis B.

Gambogic acid inhibits HBx-mediated hepatitis B virus replication by targeting the DTX1-Notch signaling pathway

[Inhibition of HBsAg and HBeAg Secretion by RNA Interference of the Polymerase Gene Sequence of Hepatitis B Virus: an Experimental Study].

Effects Of Lymphocyte Co-Culture On Proliferation And Apoptosis Of Hepatitis B Virus (Hbv)-Expressing Normal Human Mesangial Cells (Nhmcs)

Mechanisms of co-modified liver-targeting liposomes as gene delivery carriers based on cellular uptake and antigens inhibition effect.

Inhibitors of Endoplasmic Reticulum Α-Glucosidases Potently Suppress Hepatitis C Virus Virion Assembly and Release